Purchase Order W81XWH18P0149

Award Date 9/7/18
Potential Completion Date 10/13/18
Potential Value $170K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded Abbott Molecular Inc. a firm fixed-price blanket purchase agreement (BPA) call contract valued at eighty-one thousand nine hundred thirty dollars ($81,930) to provide reagents and supplies. Abbott Molecular Inc. is a subsidiary of Abbott Laboratories. The contract has a completion date of September 4, 2019 and was awarded on August 8, 2019. No set-aside designation was used for this contract. The place of performance is located in Des Plaines,...
This is a Blanket Purchase Agreement (BPA) call order awarded by the Medical Command (MEDCOM) component of the U.S. Department of the Army to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the VIROSEQ HIV-1 GT V2 KIT. The award has a firm fixed price of $91,102.00 and a performance period ending on August 12, 2015. The contract does not have a set-aside designation. Abbott Molecular is a manufacturer of diagnostic products and services that has previously provided a range of...
The Department of the Army Medical Command awarded Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a $30,980 firm fixed price call order against the Medical Products and Services Blanket Purchase Agreement for reagents and supplies in support of HIV-1 testing at the Walter Reed Army Institute of Research in Silver Spring, Maryland. No set-aside designation was applied to this contract, which has a period of performance through June 15, 2022. The call order will deliver test kits...
This federal contract award is for CHEMISTRY TESTING services provided by Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, to the Department of the Army Medical Command. The $345,447.24 Firm Fixed Price contract was awarded on October 1, 2020 with a completion date of September 30, 2021. It was not set aside for any specific business type. Through its Abbott Diagnostics Division, Abbott has extensive experience providing a variety of clinical laboratory...
The Department of the Army Medical Command awarded Abbott Molecular Inc. a $27,200 firm fixed price call against their Blanket Purchase Agreement for the VIROSEQ HIV-1 GENOTYPING SYSTEM V2.0. As the prime contractor, Abbott Molecular will provide their next generation sequencing-based in vitro diagnostic test for monitoring HIV drug resistance mutations to the Silver Spring, Maryland-based Army medical facility. Abbott Molecular is a subsidiary of Abbott Laboratories, the global healthcare...
The Department of the Army Medical Command awarded Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a $155,596 firm fixed price call against the ViroSeq HIV-1 GT V2 Genotype blanket purchase agreement to deliver genotyping services. Under this contract, Abbott Molecular will provide the Army with genotyping of HIV-1 samples to determine viral genotype for antiretroviral drug resistance interpretation. Performance will take place in Des Plaines, Illinois. No set aside designation was...
This is a $149,570 firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of the Army Medical Command to Abbott Molecular Inc., a for-profit manufacturer of molecular diagnostic products and services. The contract is for the VIROSEQ HIV-1 GT V2 GENOTYPE S, a product that supports HIV-1 genotyping services. The award was not set aside for a specific business type. Abbott Molecular has held other BPAs and Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with...
This federal contract award was issued by the Defense Health Agency to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services. The award, valued at $142,373.50, is a Blanket Purchase Agreement (BPA) call under contract number W91YTZ-12-A-0103, with a period of performance through September 30, 2016. The contract does not have a set-aside designation. Abbott Molecular has a history of providing medical...
The Department of the Army Medical Command awarded a firm fixed-price blanket purchase agreement call against an unspecified vehicle to Abbott Molecular Inc. for $78,988 to deliver the VIROSEQ HIV-1 GT V2 Genotype test kit. As the prime contractor, Abbott Molecular will provide genotyping services to identify HIV-1 virus subtypes for the Army at its facility in Des Plaines, Illinois. Abbott Laboratories is identified as the parent company of Abbott Molecular. No set-aside provision was specified...
This federal contract award is for the delivery of REAGENTS from Abbott Laboratories Inc. to the U.S. Department of the Army Medical Command (MEDCOM). The $156,353.35 firm fixed-price delivery order is issued under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) contract, a General Services Administration (GSA) indefinite delivery vehicle. No set-aside designation was used. Abbott Laboratories Inc., a global healthcare company, is the prime contractor. The award...

This federal contract award was made by the Department of the Army Medical Command to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the purchase of an M2000SP INSTRUMENT E-SERIES, which is needed to support malaria diagnostics for malaria clinical vaccine trials and Military Treatment Facilities (MTFs). The contract has a firm fixed price of $169,900.00 and a completion date of October 13, 2018.

The original solicitation was a Special Notice posted by the U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the Walter Reed Army Institute of Research (WRAIR), Military HIV Research Program (MHRP), Department of Laboratory Diagnostics and Monitoring (DLDM). This was a sole source procurement from the original equipment manufacturer, Abbott Molecular Diagnostics, Inc., as the Abbott M2000 system has been validated for the required molecular diagnostic assay and is pending FDA clearance. The contract did not utilize any set-aside designations.

Generated 3/24/24, 2:42 AM